Nascent Biotech Inc. 10-K Cybersecurity GRC - 2024-07-01

Page last updated on July 16, 2024

Nascent Biotech Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-07-01 17:30:57 EDT.

Filings

10-K filed on 2024-07-01

Nascent Biotech Inc. filed a 10-K at 2024-07-01 17:30:57 EDT
Accession Number: 0001477932-24-004020

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C: CYBERSECURITY. We are highly dependent on third-party provided software applications to conduct key operations. We depend on both our own systems as well as the systems, networks and technology of our contractors, consultants, vendors and other business partners. Our cybersecurity evaluation identifies various risks and issues that we continue to mitigate to further improve our program. This includes: · Establishing a cybersecurity training program.. · Setting up and implementing a third-party risk management program to support a Third-Party Risk Management Policy and process to assess the risks associated with our critical third-party vendor engagements. · Setting up and testing a Cybersecurity Incident Response Plan. · Establishing additional processes for identifying cybersecurity threats and vulnerabilities within the environment in which we operate. · Enhancing our technical security safeguards and configurations. Process for Assessing, Identifying and Managing Material Risks from Cybersecurity Threats In the event of a cybersecurity incident designated personnel are responsible for assessing the severity of an incident and associated threat, containing the threat, remediating the threat, including recovery of data and access to systems, analyzing any reporting obligations associated with the incident, and performing post-incident analysis and program enhancements. Our Company maintains an insurance policy through an independent insurance company for claims pursuant to a cybersecurity claim for damages.


Company Information

NameNascent Biotech Inc.
CIK0001622057
SIC DescriptionPharmaceutical Preparations
TickerNBIO - OTC
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndMarch 30